This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Wyeth. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations of Xiang Yang Tan in Monoclonal Antibodies
Introduction
Xiang Yang Tan is an accomplished inventor based in Reading, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions that have the potential to impact therapeutic applications.
Latest Patents
Xiang Yang Tan holds a patent for "Anti-TrkB monoclonal antibodies and uses thereof." This invention provides monoclonal antibodies specifically designed for human TrkB. The antibodies are notable for their ability to bind and activate human TrkB while remaining selective, as they do not bind or activate human TrkA or human TrkC. Additionally, the inventive antibodies can cross-react with murine TrkB. The patent also encompasses humanized or veneered versions of these antibodies, along with pharmaceutical compositions that include them. Methods for preparing the antibodies and their applications for treatment, detection, or purification are also detailed in the patent.
Career Highlights
Xiang Yang Tan is associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to explore and develop groundbreaking technologies in the field of monoclonal antibodies. His innovative approach has led to advancements that could enhance therapeutic options for various medical conditions.
Collaborations
Xiang Yang Tan has collaborated with notable colleagues, including Seongeun Cho and Davinder Gill. These collaborations have fostered a productive environment for research and development, contributing to the success of their projects.
Conclusion
Xiang Yang Tan's contributions to the field of monoclonal antibodies exemplify the impact of innovative research in biotechnology. His patent on Anti-TrkB monoclonal antibodies showcases his commitment to advancing medical science. The work he has done at Wyeth, along with his collaborations, highlights the importance of teamwork in achieving significant breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile